Sudden coma at the onset of severe refractory thrombotic thrombocytopenic purpura with successful treatment

被引:0
|
作者
Xu, Jingyuan [1 ]
Guan, Jiaheng [2 ]
Li, Qing [1 ]
Qian, Jie [3 ]
Wang, Yuancheng [4 ]
Huang, Yingzi [1 ]
Chen, Baoan [2 ]
Yang, Yi [1 ]
机构
[1] Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med,Jiangsu Prov Key Lab Crit Care, Nanjing 210009, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Sch Med, Dept Hematol & Oncol, Nanjing 210009, Peoples R China
[3] Suqian First Hosp, Dept Crit Care Med, Suqian 223800, Peoples R China
[4] Southeast Univ, Zhongda Hosp, Sch Med, Dept Radiol, Nanjing 210009, Peoples R China
关键词
Coma; Thrombotic thrombocytopenic purpura; Plasma exchange; TTP;
D O I
10.1016/j.transci.2021.103225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most patients develop coma several days after the onset of thrombotic thrombocytopenic purpura (TTP) caused by microvascular occlusion. However, aggravated coma as the first symptom of TTP has rarely been reported. Although plasma exchange (PEX) and steroids have reduced mortality, the prognosis of patients with TTP is still poor. We reported a patient with refractory TTP presenting with aggravated coma on admission. After days of successful PEX, rituximab, and glucocorticoid therapy for clinical remission, the patient regained consciousness and returned to his normal life with a good outcome. Our case highlights that TTP should be considered when coma occurs as the first symptom.
引用
收藏
页数:3
相关论文
共 50 条
  • [11] A CASE OF SEVERE REFRACTORY ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
    Cox, Trisana
    Tom, Jennifer
    Carter, Amanda
    Ovu, Steven
    Fuzailov, Yehuda
    CRITICAL CARE MEDICINE, 2019, 47
  • [12] Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura
    Patriquin, Christopher J.
    Thomas, Mari R.
    Dutt, Tina
    McGuckin, Siobhan
    Blombery, Piers A.
    Cranfield, Tanya
    Westwood, John P.
    Scully, Marie
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (05) : 779 - 785
  • [13] Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin
    Cosgriff, TM
    Black, ML
    Stein, W
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 57 (01) : 85 - 86
  • [14] Refractory thrombotic thrombocytopenic purpura
    Herfurth, K.
    Ruhe, J.
    Kentouche, K.
    Guenther, A.
    Braemer, D.
    Eckardt, N.
    Busch, M.
    Wolf, G.
    INNERE MEDIZIN, 2022, 63 (12): : 1307 - 1311
  • [15] Successful treatment with daratumumab for splenectomy refractory immune-mediated thrombotic thrombocytopenic purpura
    Jansen, A. J. Gerard
    Rab, Minke A. E.
    te Boekhorst, Peter A. W.
    Leebeek, Frank W. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [16] Successful Treatment With Bortezomib for Refractory and Complicated Acquired Thrombotic Thrombocytopenic Purpura in an Adolescent Girl
    Azapagasi, Ebru
    Yazici, Mutlu Uysal
    Eroglu, Nilgun
    Albayrak, Meryem
    Kucur, Ozge
    Fettah, Ali
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : E587 - E591
  • [17] Successful treatment with bortezomib for refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus
    Yan, Ruyu
    Zhou, Shuang
    Wang, Jinuo
    Yang, Huaxia
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2022, 3 (04): : 208 - 210
  • [18] Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
    Chapin, John
    Weksler, Babette
    Magro, Cynthia
    Laurence, Jeffrey
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (06) : 772 - 774
  • [19] Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura
    F. Ferrara
    C. Copia
    M. Annunziata
    A. Spasiano
    C. Di Grazia
    S. Palmieri
    L. Prossomariti
    G. Mele
    Annals of Hematology, 1999, 78 : 521 - 523
  • [20] Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura
    Ferrara, F
    Copia, C
    Annunziata, M
    Spasiano, A
    Di Grazia, C
    Palmieri, S
    Prossomariti, L
    Mele, G
    ANNALS OF HEMATOLOGY, 1999, 78 (11) : 521 - 523